EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

MADDD-seq, a novel massively parallel sequencing tool for simultaneous detection of DNA damage and mutations

Marc Vermulst iD, Samantha L Paskvan, Claire S Chung, Kathryn Franke, Nigel Clegg, Sam Minot, Jennifer Madeoy, Annalyssa S Long, Jean-Francois Gout, Jason H Bielas

Nucleic Acids Research · 2024

DOI: 10.1093/nar/gkae632 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nucleic Acids Research, 2024. Verfasst von Marc Vermulst und 9 weiteren Autor:innen. Beteiligte Einrichtung: University of Southern California, Leonard Davis School of Gerontology, Los Angeles, CA, USA. Hauptthemen laut MEDLINE: High-Throughput Nucleotide Sequencing, DNA Damage, Mutation, Saccharomyces cerevisiae. Die Arbeit nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NCI NIH HHS, NIA NIH HHS, University of Southern California.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Our genome is exposed to a wide variety of DNA-damaging agents. If left unrepaired, this damage can be converted into mutations that promote carcinogenesis or the development of genetically inherited diseases. As a result, researchers and clinicians require tools that can detect DNA damage and mutations with exceptional sensitivity. In this study, we describe a massively parallel sequencing tool termed Mutation And DNA Damage Detection-seq (MADDD-seq) that is capable of detecting O6-methyl guanine lesions and mutations simultaneously, with a single assay. To illustrate the dual capabilities of MADDD-seq, we treated WT and DNA repair deficient yeast cells with the DNA-damaging agent MNNG and tracked DNA lesions and mutations over a 24-h time period. This approach allowed us to identify thousands of DNA adducts and mutations in a single sequencing run and gain deep insight into the kinetics of DNA repair and mutagenesis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

High-Throughput Nucleotide SequencingDNA DamageMutationSaccharomyces cerevisiaeDNA RepairSequence Analysis, DNADNA AdductsMutagenesis

Substanzen

DNA Adducts

Autor:innen und Institutionen

  • University of Southern California, Leonard Davis School of Gerontology, Los Angeles, CA, USA.
  • Translational Research Program, Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
  • Data Core, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
  • Department of Biological Sciences, Mississippi State University, Mississippi State, MS, USA.
  • Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA, USA.

ORCID-Profile: Marc Vermulst

Förderung

  • NCI NIH HHS
  • NIA NIH HHS
  • University of Southern California
  • NIEHS NIH HHS
  • National Institute on Aging
  • National Cancer Institute
  • National Institute of Environmental Health Sciences

Zitieren

APA

Vermulst, M., Paskvan, S. L., Chung, C. S., Franke, K., Clegg, N., Minot, S., Madeoy, J., Long, A. S., Gout, J. F., & Bielas, J. H. (2024). MADDD-seq, a novel massively parallel sequencing tool for simultaneous detection of DNA damage and mutations. Nucleic Acids Research. https://doi.org/10.1093/nar/gkae632

Vancouver

Vermulst M, Paskvan SL, Chung CS, Franke K, Clegg N, Minot S, et al. MADDD-seq, a novel massively parallel sequencing tool for simultaneous detection of DNA damage and mutations. Nucleic Acids Research. 2024. doi:10.1093/nar/gkae632

BibTeX
@article{Vermulst2024,
  author = {Vermulst, Marc and Paskvan, Samantha L and Chung, Claire S and Franke, Kathryn and Clegg, Nigel and Minot, Sam and Madeoy, Jennifer and Long, Annalyssa S and Gout, Jean-Francois and Bielas, Jason H},
  title = {MADDD-seq, a novel massively parallel sequencing tool for simultaneous detection of DNA damage and mutations},
  journal = {Nucleic Acids Research},
  year = {2024},
  doi = {10.1093/nar/gkae632}
}
Kostenlos starten →